Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gilles Leboucher

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Presse Medicale (Paris, France : 1983)|May 25, 2010
[Impact of promotion campaigns for administering potassium orally after an accidental intravenous injection of a concentrated solution]Bruno Charpiat, Gilles Leboucher, Isabelle Martin, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 7, 2021
Implementation of a complex bone and joint infection phage therapy centre in France: lessons to be learned after 4 years' experienceTristan Ferry, Camille Kolenda, Thomas Briot, et al.
Ocular Immunology and Inflammation|February 28, 2019
Intravitreal Injections of Voriconazole for <i>Candida</i> Endophthalmitis: A Case SeriesAnne-Lise Bienvenu, Marine Aussedat, Thibaud Mathis, et al.
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|December 5, 2025
Standard formulas and individualised parenteral nutrition preparations in very low birth weight infantsLaurie Dez, Stéphane Haÿs, Gilles Leboucher, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 15, 2022
Paving the way for phage therapy using novel drug delivery approachesThomas Briot, Camille Kolenda, Tristan Ferry, et al.
Soins; La Revue De Reference Infirmiere|July 17, 2018
[Factors in the occurrence of medication errors and the use of order sets]Bruno Charpiat, Édouard Claudel, Monica Serra, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|September 7, 2019
Systematic review of artesunate pharmacokinetics: Implication for treatment of resistant malariaYobouet Ines Kouakou, Michel Tod, Gilles Leboucher, et al.
The Pediatric Infectious Disease Journal|February 25, 2016
Treatment of Congenital Toxoplasmosis: Safety of the Sulfadoxine-Pyrimethamine Combination in Children Based on a Method of Causality AssessmentJulie Teil, Damien Dupont, Bruno Charpiat, et al.
Therapie|August 10, 2012
[Clinical pharmacy and pharmacovigilance over a period of nine years in hospital]Marie-Gabrielle Guédat, Aurore Gouraud, Takeswarsing Ramiah, et al.
Antimicrobial Agents and Chemotherapy|September 25, 2004
Population pharmacokinetics of pyrimethamine and sulfadoxine in children treated for congenital toxoplasmosisStéphane Corvaisier, Bruno Charpiat, Cyril Mounier, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Presse Medicale (Paris, France : 1983)|May 25, 2010
[Impact of promotion campaigns for administering potassium orally after an accidental intravenous injection of a concentrated solution]Bruno Charpiat, Gilles Leboucher, Isabelle Martin, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 7, 2021
Implementation of a complex bone and joint infection phage therapy centre in France: lessons to be learned after 4 years' experienceTristan Ferry, Camille Kolenda, Thomas Briot, et al.
Ocular Immunology and Inflammation|February 28, 2019
Intravitreal Injections of Voriconazole for <i>Candida</i> Endophthalmitis: A Case SeriesAnne-Lise Bienvenu, Marine Aussedat, Thibaud Mathis, et al.
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|December 5, 2025
Standard formulas and individualised parenteral nutrition preparations in very low birth weight infantsLaurie Dez, Stéphane Haÿs, Gilles Leboucher, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 15, 2022
Paving the way for phage therapy using novel drug delivery approachesThomas Briot, Camille Kolenda, Tristan Ferry, et al.
Soins; La Revue De Reference Infirmiere|July 17, 2018
[Factors in the occurrence of medication errors and the use of order sets]Bruno Charpiat, Édouard Claudel, Monica Serra, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|September 7, 2019
Systematic review of artesunate pharmacokinetics: Implication for treatment of resistant malariaYobouet Ines Kouakou, Michel Tod, Gilles Leboucher, et al.
The Pediatric Infectious Disease Journal|February 25, 2016
Treatment of Congenital Toxoplasmosis: Safety of the Sulfadoxine-Pyrimethamine Combination in Children Based on a Method of Causality AssessmentJulie Teil, Damien Dupont, Bruno Charpiat, et al.
Therapie|August 10, 2012
[Clinical pharmacy and pharmacovigilance over a period of nine years in hospital]Marie-Gabrielle Guédat, Aurore Gouraud, Takeswarsing Ramiah, et al.
Antimicrobial Agents and Chemotherapy|September 25, 2004
Population pharmacokinetics of pyrimethamine and sulfadoxine in children treated for congenital toxoplasmosisStéphane Corvaisier, Bruno Charpiat, Cyril Mounier, et al.
Pageof 4